Search for: "Novartis Ag"
Results 181 - 200
of 440
Sort by Relevance
|
Sort by Date
16 Jul 2014, 9:31 pm
Reg. 34681) discussing changes to the rules of practice to implement the Federal Circuit's decision in Novartis AG v. [read post]
29 Jun 2014, 9:21 pm
Mylan Inc. et al. 1:14-cv-00777; filed June 19, 2014 in the District Court of Delaware • Plaintiffs: Novartis Pharmaceuticals Corp.; Novartis AG; Novartis Pharma AG; LTS Lohmann Therapie-Systeme AG • Defendants: Mylan Inc.; Mylan Pharmaceuticals Inc. [read post]
26 Jun 2014, 7:44 am
Recently, the United States Patent and Trademark Office proposed changes to the rules of practice pertaining to the patent term adjustment provisions in view of the decision by the United States Court of Appeals for the Federal Circuit in Novartis AG v. [read post]
23 May 2014, 1:39 pm
Novartis AG, California Superior Court, Los Angeles Cty., Transcript of Oral Argument on Post-Trial Motions, at 46 -47 (March 18, 2004) (Hon. [read post]
19 Apr 2014, 8:50 am
On Good Friday, April 18, 2014, Chief Justice Roberts, denied Teva a request for a stay in the Copaxone case, noting that he was not convinced Teva had shown the "likelihood of irreparable harm" if the application was denied, because if Teva wins the Supreme Court case it can seek damages from the generic companies for past infringement on its patents.In this case, Teva, a known generic manufacturer, is in the role of proprietary drug maker, fighting the generic arm of a proprietary company… [read post]
13 Apr 2014, 9:43 pm
Reddy's Laboratories Ltd. et al. 1:14-cv-00387; filed March 26, 2014 in the District Court of Delaware • Plaintiffs: Novartis Pharmaceuticals Corp.; Novartis AG • Defendants: Dr. [read post]
11 Apr 2014, 2:20 am
Off-label uses are those uses for which drugs have not been officially approved by drug regulators, eg different therapeutic indications, patient age range or dose instructions [this explanation was vital to this Kat to understand what Silvia was talking about]. [read post]
20 Feb 2014, 9:30 pm
Novartis AG, [2013] EWCA Civ. 1663 was issued on 19 December 2013. [read post]
9 Feb 2014, 9:15 pm
Reddy's Laboratories Ltd. et al. 1:14-cv-00157; filed February 5, 2014 in the District Court of Delaware • Plaintiffs: Novartis Pharmaceuticals Corp.; Novartis AG • Defendants: Dr. [read post]
3 Feb 2014, 9:51 pm
Noven Pharmaceuticals Inc. et al. 1:14-cv-00111; filed January 30, 2014 in the District Court of Delaware • Plaintiffs: Novartis Pharmaceuticals Corp.; Novartis AG; Novartis Pharma AG; Novartis International Pharmaceutical, LTD; LTS Lohmann Therapie-Systeme AG • Defendants: Noven Pharmaceuticals Inc.; Noven Therapeutics LLC; Hisamitsu Pharmaceutical Co. [read post]
24 Jan 2014, 6:31 am
A new court decision (Novartis AG v. [read post]
16 Jan 2014, 7:31 pm
Procedural HistoryNovartis AG, Novartis Vaccines and Diagnostics, Inc., and Novartis Corporation (collectively, Novartis) filed suits that challenged the determinations by the Patent and Trademark Office of how much time to add, under 35 U.S.C. [read post]
15 Jan 2014, 9:59 pm
Patent and Trademark Office for fifteen patents were untimely asserted by Novartis AG, Novartis Vaccines and Diagnostics, Inc., and Novartis Corporation ("Novartis"). [read post]
15 Jan 2014, 1:45 pm
The Federal Circuit issued its decision in the pending Patent Term Adjustment (PTA) appeals, resolving the issues raised in Exelixis I, Exelixis II and Novartis, in a precedential decision issued in Novatris AG v. [read post]
9 Jan 2014, 1:37 pm
We’ve covered a lot of topics since we started DDLaw in late 2006. [read post]
30 Dec 2013, 5:25 am
Happy New Year from all of us here at DDLaw! [read post]
1 Dec 2013, 8:49 pm
Roxane Laboratories, Inc. 2:13-cv-07184; filed November 27, 2013 in the District Court of New Jersey • Plaintiffs: Novartis Pharmaceuticals Corp.; Novartis Pharma AG; Aventisub II Inc. [read post]
11 Oct 2013, 8:30 am
Rea and Novartis AG v. [read post]
29 Aug 2013, 8:20 am
Novartis, Case No.: 04-CV-9194 (S.D.N.Y. [read post]
Judge Robinson grants motion for leave to amend complaint 9 months after deadline to amend pleadings
26 Jul 2013, 7:48 am
Plaintiffs previously filed a first amended complaint, and then a supplemental complaint adding Novartis Pharma AG, exclusive licensee of the patent-in-suit, as a co-plaintiff. [read post]
